BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36202317)

  • 1. Synchrotron Fourier-Transform Infrared Microspectroscopy: Characterization of in vitro polarized tumor-associated macrophages stimulated by the secretome of inflammatory and non-inflammatory breast cancer cells.
    Mohamed HT; Kamel G; El-Husseiny N; El-Sharkawy AA; El-Sherif AA; El-Shinawi M; Mohamed MM
    Biochim Biophys Acta Mol Cell Res; 2023 Jan; 1870(1):119367. PubMed ID: 36202317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory Breast Cancer: The Secretome of HCMV
    Mohamed HT; El-Sharkawy AA; El-Shinawi M; Schneider RJ; Mohamed MM
    Front Oncol; 2022; 12():899622. PubMed ID: 35847899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines secreted by macrophages isolated from tumor microenvironment of inflammatory breast cancer patients possess chemotactic properties.
    Mohamed MM; El-Ghonaimy EA; Nouh MA; Schneider RJ; Sloane BF; El-Shinawi M
    Int J Biochem Cell Biol; 2014 Jan; 46():138-47. PubMed ID: 24291763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infrared Microspectroscopy and Imaging Analysis of Inflammatory and Non-Inflammatory Breast Cancer Cells and Their GAG Secretome.
    Mohamed HT; Untereiner V; Cinque G; Ibrahim SA; Götte M; Nguyen NQ; Rivet R; Sockalingum GD; Brézillon S
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32961706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-10 correlates with the expression of carboxypeptidase B2 and lymphovascular invasion in inflammatory breast cancer: The potential role of tumor infiltrated macrophages.
    Mohamed HT; El-Husseiny N; El-Ghonaimy EA; Ibrahim SA; Bazzi ZA; Cavallo-Medved D; Boffa MB; El-Shinawi M; Mohamed MM
    Curr Probl Cancer; 2018; 42(2):215-230. PubMed ID: 29459177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-8 and MCP-1/CCL2 regulate proteolytic activity in triple negative inflammatory breast cancer a mechanism that might be modulated by Src and Erk1/2.
    Mohamed HT; El-Ghonaimy EA; El-Shinawi M; Hosney M; Götte M; Woodward WA; El-Mamlouk T; Mohamed MM
    Toxicol Appl Pharmacol; 2020 Aug; 401():115092. PubMed ID: 32512068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of adipose tissue-derived cytokines in the progression of inflammatory breast cancer in patients with obesity.
    Ibrahim AS; El-Shinawi M; Sabet S; Ibrahim SA; Mohamed MM
    Lipids Health Dis; 2022 Aug; 21(1):67. PubMed ID: 35927653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of heparanase via IL-10 correlates with a high infiltration of CD163+ M2-type tumor-associated macrophages in inflammatory breast carcinomas.
    El-Nadi M; Hassan H; Saleh ME; Nassar E; Ismail YM; Amer M; Greve B; Götte M; El-Shinawi M; Ibrahim SA
    Matrix Biol Plus; 2020 May; 6-7():100030. PubMed ID: 33543027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Gene Expression of fresh tissue and patient-derived explants' matricellular proteins augment inflammatory breast cancer metastasis: the possible role of IL-6 and MCP-1.
    Tarek A; Mohamed HT; El-Sharkawy AA; El-Sayed SK; Hirshon JM; Woodward WA; El-Shinawi M; Mohamed MM
    QJM; 2023 May; 116(5):345-354. PubMed ID: 36592055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.
    Ibrahim SA; Gadalla R; El-Ghonaimy EA; Samir O; Mohamed HT; Hassan H; Greve B; El-Shinawi M; Mohamed MM; Götte M
    Mol Cancer; 2017 Mar; 16(1):57. PubMed ID: 28270211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering the role of interferon alpha signaling and microenvironment crosstalk in inflammatory breast cancer.
    Provance OK; Lewis-Wambi J
    Breast Cancer Res; 2019 May; 21(1):59. PubMed ID: 31060575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory Breast Cancer Promotes Development of M2 Tumor-Associated Macrophages and Cancer Mesenchymal Cells through a Complex Chemokine Network.
    Valeta-Magara A; Gadi A; Volta V; Walters B; Arju R; Giashuddin S; Zhong H; Schneider RJ
    Cancer Res; 2019 Jul; 79(13):3360-3371. PubMed ID: 31043378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking Interleukin (IL)4- and IL13-Mediated Phosphorylation of STAT6 (Tyr641) Decreases M2 Polarization of Macrophages and Protects Against Macrophage-Mediated Radioresistance of Inflammatory Breast Cancer.
    Rahal OM; Wolfe AR; Mandal PK; Larson R; Tin S; Jimenez C; Zhang D; Horton J; Reuben JM; McMurray JS; Woodward WA
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):1034-1043. PubMed ID: 29485045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CD151-midkine pathway regulates the immune microenvironment in inflammatory breast cancer.
    Hayward S; Gachehiladze M; Badr N; Andrijes R; Molostvov G; Paniushkina L; Sopikova B; Slobodová Z; Mgebrishvili G; Sharma N; Horimoto Y; Burg D; Robertson G; Hanby A; Hoar F; Rea D; Eckhardt BL; Ueno NT; Nazarenko I; Long HM; van Laere S; Shaaban AM; Berditchevski F
    J Pathol; 2020 May; 251(1):63-73. PubMed ID: 32129471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of inflammatory breast cancer: a vibrational microspectroscopy and imaging approach at the cellular and tissue level.
    Mohamed HT; Untereiner V; Proult I; Ibrahim SA; Götte M; El-Shinawi M; Mohamed MM; Sockalingum GD; Brézillon S
    Analyst; 2018 Dec; 143(24):6103-6112. PubMed ID: 30468236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammary stem cell and macrophage markers are enriched in normal tissue adjacent to inflammatory breast cancer.
    Reddy JP; Atkinson RL; Larson R; Burks JK; Smith D; Debeb BG; Ruffell B; Creighton CJ; Bambhroliya A; Reuben JM; Van Laere SJ; Krishnamurthy S; Symmans WF; Brewster AM; Woodward WA
    Breast Cancer Res Treat; 2018 Sep; 171(2):283-293. PubMed ID: 29858753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy.
    Jhaveri K; Teplinsky E; Silvera D; Valeta-Magara A; Arju R; Giashuddin S; Sarfraz Y; Alexander M; Darvishian F; Levine PH; Hashmi S; Zolfaghari L; Hoffman HJ; Singh B; Goldberg JD; Hochman T; Formenti S; Esteva FJ; Moran MS; Schneider RJ
    Clin Breast Cancer; 2016 Apr; 16(2):113-22.e1. PubMed ID: 26774497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of molecular profile in triple-negative inflammatory and non-inflammatory breast cancer not of mesenchymal stem-like subtype.
    Funakoshi Y; Wang Y; Semba T; Masuda H; Hout D; Ueno NT; Wang X
    PLoS One; 2019; 14(9):e0222336. PubMed ID: 31532791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Subpopulation of Luminal Progenitors Secretes Pleiotrophin to Promote Angiogenesis and Metastasis in Inflammatory Breast Cancer.
    Zhang M; Zhou K; Wang Z; Liu T; Stevens LE; Lynce F; Chen WY; Peng S; Xie Y; Zhai D; Chen Q; Shi Y; Shi H; Yuan Z; Li X; Xu J; Cai Z; Guo J; Shao N; Lin Y
    Cancer Res; 2024 Jun; 84(11):1781-1798. PubMed ID: 38507720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophages Enhance Migration in Inflammatory Breast Cancer Cells via RhoC GTPase Signaling.
    Allen SG; Chen YC; Madden JM; Fournier CL; Altemus MA; Hiziroglu AB; Cheng YH; Wu ZF; Bao L; Yates JA; Yoon E; Merajver SD
    Sci Rep; 2016 Dec; 6():39190. PubMed ID: 27991524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.